Biotech Innovations: The Future Is In Our Hands.

In 2012 I earned my Master Degree in Systems Engineering. I remember sitting in the audience at the Fox Theatre in downtown Atlanta, waiting to walk across the stage to pick up my diploma from the president of Georgia Tech.

At the time, I recalled my undergraduate graduation 7 years earlier. The keynote speaker had blabbed on for what felt like an eternity about energy policy. Fast forward, and there I was dreading another mind-numbing keynote address.

I was pleasantly surprised when they introduced a very well-spoken engineering professor who gave an urgent, important message to a room full of engineers with newly minted diplomas.

No one has a crystal ball,” he told us. “So if you want to predict the future, the only true way is to invent it yourself.

Make no mistake: Nerds like us are forging the way to a better future,

Every year since 2001, the Massachusetts Institute of Technology — better known as MIT — releases their list of the top 10 technological innovations that will change the world.

This year, two of the top 10 fall under the umbrella of biotech:  “Internet of DNA” and “liquid biopsy.”

As you have probably already guessed from my previous articles, Internet of DNA is the current breakthrough of sharing millions of DNA database records, closely aligned with the precision medicine initiative.

With this information, doctors will be able to compare your DNA and symptoms to another patient with the same condition. MIT believes we’ll see this roll out into standard medical treatment in the next one to two years.

Then there’s liquid biopsy. This is a technology that will allow us to identify small quantities of cancerous cells from trace amounts of DNA in the blood stream — all from a simple blood test!  This will allow for earlier detection and treatment for cancer patients.

We are only now starting to reach a major tipping point in biotech innovation… and it’s all fueled by highly capable engineers and scientists working hand–in-hand to invent the future, using the latest technology in advanced computing machines.

Stay tuned next week as I continue to update you on the market’s latest health and biotech trends.

Image Signature

Ben

Editor, BioTech Intel Trader

Categories: Biotech

About Author

Ben Benoy is a veteran of the U.S. Marine Corps and has been an active retail trader since 2006. He identifies investment opportunities based on key social media trends. He first identified the concept in 2008 and has since developed a tool for tracking investment “chatter” between social media users. His proprietary Social Media Stock Sentiment system has developed into a state-of-the-art platform that identifies and classifies chatter about stocks through algorithms and other indicators to forecast stock-price direction. Ben’s track record speaks for itself — over the past 12 months, his system boasts a win rate of 82.2% on 112 stock trades.